Twist Bioscience reported $21.9M of remaining performance obligations at 30 Jun 2026, up 63% from a year earlier and up 32% from the previous quarter. That is 0.1 years of trailing revenue already under contract. Book-to-bill last quarter: 1.04.
Net new backlog added in the latest quarter: $5.30M.
74% of the backlog is due within the next twelve months.
Customer prepayments (contract liabilities) cover 29.7% of the backlog.
Twelve-month book-to-bill: 1.02, i.e. 1.02 of new orders for every 1 of revenue recognised.
Backlog growth minus revenue growth: +44 points — orders are running ahead of revenue.
By backlog size it ranks 503rd among US filers the cockpit tracks.
Twist Bioscience backlog history
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter end
Backlog (RPO)
TTM revenue
Coverage
Customer prepayments
30 Jun 2026
$21.9M
$432M
0.1 yrs
$6.50M
31 Mar 2026
$16.6M
$410M
0.0 yrs
$7.10M
31 Dec 2025
$19.0M
$392M
0.0 yrs
$9.00M
30 Sep 2025
$15.1M
$377M
0.0 yrs
$6.90M
30 Jun 2025
$13.4M
$362M
0.0 yrs
$6.20M
31 Mar 2025
$8.50M
$348M
0.0 yrs
$2.00M
31 Dec 2024
$8.10M
$330M
0.0 yrs
$1.40M
30 Sep 2024
$8.60M
$313M
0.0 yrs
$2.10M
30 Jun 2024
$7.10M
$295M
0.0 yrs
$2.90M
31 Mar 2024
$5.90M
$278M
0.0 yrs
$2.50M
31 Dec 2023
$7.30M
$262M
0.0 yrs
$2.60M
30 Sep 2023
$5.30M
$245M
0.0 yrs
$3.00M
Questions
What is Twist Bioscience's backlog?
Twist Bioscience reported $21.9M of remaining performance obligations at 30 Jun 2026, up 63% from a year earlier and up 32% from the previous quarter. That is 0.1 years of trailing revenue already under contract. Book-to-bill last quarter: 1.04.
About these numbers
Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.